Crystal structure of the complex of the cyclin D dependent kinase Cdk6 bound to the cell-cycle inhibitor p19INK4d

被引:173
作者
Brotherton, DH
Dhanaraj, V
Wick, S
Brizuela, L
Domaille, PJ
Volyanik, E
Xu, X
Parisini, E
Smith, BO
Archer, SJ
Serrano, M
Brenner, SL
Blundell, TL
Laue, ED
机构
[1] Univ Cambridge, Dept Biochem, Cambridge Ctr Mol Recognit, Cambridge CB2 1GA, England
[2] Mitotix Inc, Cambridge, MA 02139 USA
[3] Dupont Merck Pharmaceut Co, Wilmington, DE 19880 USA
[4] Ctr Nacl Biotecnol, Dept Immunol & Oncol, E-28049 Madrid, Spain
基金
英国惠康基金;
关键词
D O I
10.1038/26164
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The crystal structure of the cyclin D-dependent kinase Cdk6 bound to the p19(INK4d) protein has been determined at 1.9 Angstrom resolution. The results provide the first structural Information for a cyclin D-dependent protein kinase and show how the INK4 family of CDK inhibitors bind. The structure indicates that the conformational changes Induced by p19(INK4d) Inhibit both productive binding of ATP and the cyclin-induced rearrangement of the kinase from an Inactive to an active conformation. The structure also shows how binding of an INK4 inhibitor would prevent binding of p27(Kip1), resulting In Its redistribution to other CDKs. identification of the critical residues involved in the Interaction explains how mutations in Cdk4 and p16(INK4a) result in loss of kinase inhibition and cancer.
引用
收藏
页码:244 / 250
页数:7
相关论文
共 49 条
[11]   Structure of the p53 tumor suppressor bound to the ankyrin and SH3 domains of 53BP2 [J].
Gorina, S ;
Pavletich, NP .
SCIENCE, 1996, 274 (5289) :1001-1005
[12]   Isolation and characterization of p19(INK4d), a p16-related inhibitor specific to CDK6 and CDK4 [J].
Guan, KL ;
Jenkins, CW ;
Li, Y ;
OKeefe, CL ;
Noh, S ;
Wu, XY ;
Zariwala, M ;
Matera, AG ;
Xiong, Y .
MOLECULAR BIOLOGY OF THE CELL, 1996, 7 (01) :57-70
[13]   P15(INK4B) IS A POTENTIAL EFFECTOR OF TGF-BETA-INDUCED CELL-CYCLE ARREST [J].
HANNON, GJ ;
BEACH, D .
NATURE, 1994, 371 (6494) :257-261
[14]  
Harper JW, 1997, CANCER SURV, V29, P91
[15]  
HIRAI H, 1995, MOL CELL BIOL, V15, P2672
[16]  
Hubbard S. J., 1993, NACCESS COMPUTER PRO
[17]   MECHANISM OF CDK ACTIVATION REVEALED BY THE STRUCTURE OF A CYCLINA-CDK2 COMPLEX [J].
JEFFREY, PD ;
RUSO, AA ;
POLYAK, K ;
GIBBS, E ;
HURWITZ, J ;
MASSAGUE, J ;
PAVLETICH, NP .
NATURE, 1995, 376 (6538) :313-320
[18]   IMPROVED METHODS FOR BUILDING PROTEIN MODELS IN ELECTRON-DENSITY MAPS AND THE LOCATION OF ERRORS IN THESE MODELS [J].
JONES, TA ;
ZOU, JY ;
COWAN, SW ;
KJELDGAARD, M .
ACTA CRYSTALLOGRAPHICA SECTION A, 1991, 47 :110-119
[19]   MOLSCRIPT - A PROGRAM TO PRODUCE BOTH DETAILED AND SCHEMATIC PLOTS OF PROTEIN STRUCTURES [J].
KRAULIS, PJ .
JOURNAL OF APPLIED CRYSTALLOGRAPHY, 1991, 24 :946-950
[20]   THE CDC25 PROTEIN CONTROLS TYROSINE DEPHOSPHORYLATION OF THE CDC2 PROTEIN IN A CELL-FREE SYSTEM [J].
KUMAGAI, A ;
DUNPHY, WG .
CELL, 1991, 64 (05) :903-914